TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15459246

Group type: EXPERIMENTAL
Intervention: Melatonin (1.5 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 10910871

Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg melatonin
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg melatonin
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg melatonin
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg midazolam
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg midazolam
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg midazolam
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 8725276

Group type: EXPERIMENTAL
Intervention: 100% O2
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Heliox (79% He, 21% O2)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Comparison of heliox and oxygen
Number of subjects: 14
Study: 1313637

Group type: EXPERIMENTAL
Intervention: Azithromycin, 500 mg on the first day followed by 250 mg once a day for 4 days
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Amoxicillin 500 mg and probenecid 500 mg, three times a day for 10 days
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Doxycycline, 100 mg twice a day for 10 days
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Amoxicillin/probenecid or doxycycline extended treatment if symptoms were still present at 10 days
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Overall treatment effectiveness of the three regimens
Number of subjects: 57
Study: 3905440

Group type: EXPERIMENTAL
Intervention: RSV (1, 2‐diphenyl‐alpha beta‐diketone)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: herbs
Number of subjects: 152

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 152
Study: 31647425

Group type: EXPERIMENTAL
Intervention: JSR-ES (joint spectral reconstruction with energy-window subset algorithm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: JSR-ES
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multi-band forward modeling with a single acquisition window
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-band forward modeling with a single acquisition window
Number of subjects: 0
Study: 31929849

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 62

Group type: COMPARATOR
Intervention: Ibuprofen administration
Number of subjects: 62
Study: 28743821

Group type: EXPERIMENTAL
Intervention: NO3‐‐rich beetroot juice (BR; providing 8.4 mmol NO3‐∙day‐1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: NO3‐‐depleted beetroot juice (placebo; PLA)
Number of subjects: 8
Study: 26518021

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral stress management (CBSM) intervention, 10-week, group-based
Number of subjects: 240

Group type: COMPARATOR
Intervention: 1‐day psychoeducational seminar
Number of subjects: 240
Study: 23085891

Group type: EXPERIMENTAL
Intervention: Persistent regular diets
Number of subjects: 100

Group type: COMPARATOR
Intervention: Alternating diets (2 different complete chows)
Number of subjects: 100
Study: 21865203

Group type: EXPERIMENTAL
Intervention: BMI ≥30 kg/m2
Number of subjects: 6560

Group type: COMPARATOR
Intervention: BMI <25 kg/m2
Number of subjects: 6560

Group type: EXPERIMENTAL
Intervention: BMI groups stratified by WC
Number of subjects: 6560

Group type: EXPERIMENTAL
Intervention: 30-day to 1-year outcomes
Number of subjects: 6560
Study: 19118301

Group type: EXPERIMENTAL
Intervention: Machine perfusion
Number of subjects: 672

Group type: COMPARATOR
Intervention: Cold storage
Number of subjects: 672
Study: 17208082

Group type: EXPERIMENTAL
Intervention: Long-term low-molecular-weight heparin (LMWH) therapy (tinzaparin)
Number of subjects: 737

Group type: COMPARATOR
Intervention: Usual care (vitamin K antagonist therapy)
Number of subjects: 737
Study: 15389185

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 141

Group type: COMPARATOR
Intervention: Tacrolimus ointment 0.03%
Number of subjects: 141
Study: 11524191

Group type: EXPERIMENTAL
Intervention: Topical lidocaine hydrochloride 2% (5 doses, 2 drops per dose) before phacoemulsification and foldable IOL implantation
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Topical lidocaine hydrochloride 2%
Number of subjects: 388

Group type: COMPARATOR
Intervention: Control group (patients with cataract and no glaucoma)
Number of subjects: 388
Study: 9627287

Group type: EXPERIMENTAL
Intervention: Salpingectomy followed by IVF with combined GnRH agonist and hMG therapy
Number of subjects: 60
Study: 7947102

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil and interferon alpha (5-FU/IFN-alpha)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 5-fluorouracil and leucovorin (5-FU/L-leucovorin)
Number of subjects: 24
Study: 3311552

Group type: COMPARATOR
Intervention: Normal diet (100 gm/70 kg protein/day)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Restricted diet (19 gm/70 kg protein/day)
Number of subjects: 5
Study: 31928931

Group type: COMPARATOR
Intervention: Multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors
Number of subjects: 0
Study: 30664114

Group type: EXPERIMENTAL
Intervention: Passive static stretching for 120 seconds
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Passive static stretching for 30 seconds
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Passive static stretching for 60 seconds
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 13
Study: 28505470

Group type: EXPERIMENTAL
Intervention: Multi-faceted food response and attention training with personalized high- and low-calorie food images
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control training with non-food images
Number of subjects: 0
Study: 25163656

Group type: EXPERIMENTAL
Intervention: Group A (lower two-thirds of the rectum)
Number of subjects: 725

Group type: EXPERIMENTAL
Intervention: Group B (upper third of the rectum and rectosigmoid junction)
Number of subjects: 725

Group type: COMPARATOR
Intervention: Group C (colon)
Number of subjects: 725

Group type: COMPARATOR
Intervention: Comparison of Group A to Group C
Number of subjects: 725

Group type: COMPARATOR
Intervention: Comparison of Group B to Group C
Number of subjects: 725
Study: 23356656

Group type: EXPERIMENTAL
Intervention: Normative message (stress causes ill health)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counter-normative message (stress provides challenge, growth, and development)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 21734588

Group type: EXPERIMENTAL
Intervention: Pregabalin (450 mg/day)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study: 19498345

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (approximately 1,000 fewer calories per day for 9 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (weight stability maintained for 4 weeks after randomization)
Number of subjects: 60
Study: 17106345

Group type: EXPERIMENTAL
Intervention: Telephone follow-up intervention by specially trained nurses over 1 year
Number of subjects: 343

Group type: COMPARATOR
Intervention: Control group received written information only
Number of subjects: 343
Study: 15557371

Group type: COMPARATOR
Intervention: On-pump surgery (n=192)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Off-pump surgery (n=208)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Other arteries (off-pump)
Number of subjects: 400
Study: 14656781

Group type: EXPERIMENTAL
Intervention: Morphine 0.05 mg with tetracaine
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Morphine 0.10 mg with tetracaine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Tetracaine 10 mg alone
Number of subjects: 42
Study: 11078064

Group type: EXPERIMENTAL
Intervention: Immunohistochemistry of attic cholesteatomas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follow-up studies on patients with attic retractions
Number of subjects: 0
Study: 8962928

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 36

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 36

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 36
Study: 1480451

Group type: EXPERIMENTAL
Intervention: EMLA patch
Number of subjects: 160

Group type: COMPARATOR
Intervention: EMLA cream
Number of subjects: 160
Study: 2933057

Group type: COMPARATOR
Intervention: Bladder catheterization
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: No catheterization
Number of subjects: 83
Study: 30099859

Group type: EXPERIMENTAL
Intervention: Wearing a soft knee brace
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 44
Study: 30552275

Group type: EXPERIMENTAL
Intervention: Chocolate containing 99% cocoa, 10g daily for 6 months
Number of subjects: 140

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 140
Study: 26222203

Group type: EXPERIMENTAL
Intervention: Systemic glucocorticosteroids
Number of subjects: 1
Study: 25163019

Group type: EXPERIMENTAL
Intervention: Valacyclovir 1 g twice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 22650270

Group type: EXPERIMENTAL
Intervention: Placebo group (N = 15)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Nocebo group (N = 17)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (N = 15)
Number of subjects: 47
Study: 21086563

Group type: EXPERIMENTAL
Intervention: Endotics system (ES)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Video-colonoscopy
Number of subjects: 71
Study: 18322739

Group type: EXPERIMENTAL
Intervention: MIVAT
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional thyroidectomy
Number of subjects: 30
Study: 16026368

Group type: EXPERIMENTAL
Intervention: Sibutramine 15 mg/day
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 12421835

Group type: EXPERIMENTAL
Intervention: Maternal vitamin A supplementation (60 mg retinol palmitate at 18-42 days postpartum)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infant vitamin A supplementation (7.5 mg at 6, 10, and 14 weeks of age)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (for both mothers and infants)
Number of subjects: 0
Study: 10592404

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS), given once daily for 1 week
Number of subjects: 5
Study: 7475716

Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (Meningococcal vaccine)
Number of subjects: 55
Study: 2206119

Group type: EXPERIMENTAL
Intervention: Gastric restrictive procedures
Number of subjects: 240
Study: 6986945

Group type: EXPERIMENTAL
Intervention: Stanozolol plus elastic stockings
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo plus elastic stockings
Number of subjects: 23
Study: 31724501

Group type: EXPERIMENTAL
Intervention: Chlorhexidine brush-on gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 30
Study: 28651681

Group type: COMPARATOR
Intervention: 0 mg of Ca (as calcium carbonate)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 500 mg of Ca (as calcium carbonate)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 1000 mg of Ca (as calcium carbonate)
Number of subjects: 25
Study: 25976603

Group type: EXPERIMENTAL
Intervention: Jaw thrust-assisted technique
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional group (anterior jaw lift technique)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 23952776

Group type: EXPERIMENTAL
Intervention: Teaching methodologies (specific methodologies not detailed)
Number of subjects: 0
Study: 21576473

Group type: EXPERIMENTAL
Intervention: NVP-containing treatment arm
Number of subjects: 232

Group type: COMPARATOR
Intervention: lopinavir/ritonavir-containing treatment arm
Number of subjects: 232
Study: 20179410

Group type: EXPERIMENTAL
Intervention: Aspartame
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sucrose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (non-psychiatric)
Number of subjects: 0
Study: 16736729

Group type: EXPERIMENTAL
Intervention: Nalpha‐methylhistamine 1 to 3 ng twice a week
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 15311117

Group type: EXPERIMENTAL
Intervention: Tc‐99m MIBI scintigraphy (30 and 120 minutes)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Tc‐99m MIBI scintigraphy (120 minutes)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Tc‐99m MIBI scintigraphy (30 minutes)
Number of subjects: 77
Study: 11314153

Group type: EXPERIMENTAL
Intervention: Entry into randomized controlled trial (RCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Onerous procedures (such as intramuscular injections)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Best interest deliberation
Number of subjects: 0
Study: 9505785

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 72
Study: 8001531

Group type: EXPERIMENTAL
Intervention: Drink A (90 mmol.l-1 glucose solution)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Drink B (60 mmol.l-1 sodium chloride)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Drink C (25 mmol.l-1 potassium chloride)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Drink D (90 mmol.l-1 glucose, 60 mmol.l-1 sodium chloride and 25 mmol.l-1 potassium chloride)
Number of subjects: 8
Study: 3355619

Group type: EXPERIMENTAL
Intervention: 5 g of encapsulated fish oil per day
Number of subjects: 31

Group type: COMPARATOR
Intervention: 5 g of encapsulated safflower oil (placebo) per day
Number of subjects: 31
Study: 7930868

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 699484

Group type: COMPARATOR
Intervention: Diazepam with water
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Diazepam with magnesium aluminum hydroxide (Maalox)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Diazepam with aluminum hydroxide trisilicate (Gelusil)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Diazepam with food
Number of subjects: 9
Study: 31851799

Group type: EXPERIMENTAL
Intervention: Olaparib plus Bevacizumab
Number of subjects: 806

Group type: COMPARATOR
Intervention: Placebo plus Bevacizumab
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Olaparib plus Bevacizumab (HRD-positive tumors with BRCA mutations)
Number of subjects: 806

Group type: COMPARATOR
Intervention: Placebo plus Bevacizumab (HRD-positive tumors with BRCA mutations)
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Olaparib plus Bevacizumab (HRD-positive tumors without BRCA mutations)
Number of subjects: 806

Group type: COMPARATOR
Intervention: Placebo plus Bevacizumab (HRD-positive tumors without BRCA mutations)
Number of subjects: 806
Study: 28692122

Group type: EXPERIMENTAL
Intervention: IL-18 gene polymorphisms -656 G/T and -607 C/A
Number of subjects: 150
Study: 26837842

Group type: EXPERIMENTAL
Intervention: Nilotinib 300 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nilotinib 400 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imatinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nilotinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All arms
Number of subjects: 0
Study: 24621390

Group type: EXPERIMENTAL
Intervention: Unlimited access to lactation consultants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care at the well-baby clinics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infants exclusively breastfed for 6 months
Number of subjects: 0
Study: 22197578

Group type: EXPERIMENTAL
Intervention: AZD9668 60 mg bid
Number of subjects: 615

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 615
Study: 19729935

Group type: EXPERIMENTAL
Intervention: Cantharidin blister applied once for 12 hours after a 3-day run-in phase.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (waiting list).
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cantharidin blister vs Control group.
Number of subjects: 28
Study: 17597704

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observational studies
Number of subjects: 0
Study: 12529868

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11197046

Group type: EXPERIMENTAL
Intervention: Eradication therapy (30 mg lansoprazole once a day, 400 mg clarithromycin twice a day, 1000 mg amoxicillin twice a day, 300 mg rebamipide three times a day for one week)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Lansoprazole (LPZ)
Number of subjects: 15
Study: 8837978

Group type: EXPERIMENTAL
Intervention: Clomipramine (CMI)
Number of subjects: 21
Study: 1430250

Group type: EXPERIMENTAL
Intervention: Novel biofeedback
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Standard biofeedback
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control
Number of subjects: 49
Study: 2864221

Group type: COMPARATOR
Intervention: Beta 2‐agonist therapy alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Beta 2‐agonist therapy in combination with theophylline
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Beta 2‐agonist therapy in combination with enprofylline
Number of subjects: 20
Study: 31138577

Group type: EXPERIMENTAL
Intervention: Cefoperazone-sulbactam (2 g of each per 12 h)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Cefepime (2 g per 12 h)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Cefoperazone-sulbactam and Cefepime
Number of subjects: 154
Study: 27840383

Group type: EXPERIMENTAL
Intervention: Alogliptin 25 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alogliptin 25 mg/day (switch from sitagliptin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vildagliptin 50 mg twice daily (switch from sitagliptin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 0
Study: 26174133

Group type: EXPERIMENTAL
Intervention: 1 mg melatonin
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 3 mg melatonin
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 23965840

Group type: EXPERIMENTAL
Intervention: MedCheck intervention (automated electronic message in a patient Internet portal)
Number of subjects: 738

Group type: COMPARATOR
Intervention: Control group (no MedCheck intervention)
Number of subjects: 738
Study: 20926967

Group type: EXPERIMENTAL
Intervention: Rest interval of 60 seconds
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Rest interval of 90 seconds
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Rest interval of 120 seconds
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Rest interval of 180 seconds
Number of subjects: 10
Study: 20003515

Group type: EXPERIMENTAL
Intervention: Group hearing aid fitting and follow-up visits
Number of subjects: 659

Group type: COMPARATOR
Intervention: Individual hearing aid fitting and follow-up visits
Number of subjects: 659

Group type: COMPARATOR
Intervention: Group visits
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: Individual visits
Number of subjects: 659
Study: 17069923

Group type: EXPERIMENTAL
Intervention: Empowerment group education
Number of subjects: 101

Group type: COMPARATOR
Intervention: Routine diabetes care
Number of subjects: 101
Study: 15289793

Group type: EXPERIMENTAL
Intervention: 10 mg rosuvastatin for 10 days
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 20 mg rosuvastatin for 10 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: 10 mg rosuvastatin (historical data)
Number of subjects: 10
Study: 11410117

Group type: EXPERIMENTAL
Intervention: Low-sodium (50 mmol/day), low-nitrate (400 micromol/day) diet supplemented with NaCl tablets (200 mmol/day) for 7 days
Number of subjects: 50
Study: 9240301

Group type: EXPERIMENTAL
Intervention: Heparin-coated extracorporeal circuit (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Uncoated extracorporeal circuit (n = 15)
Number of subjects: 30
Study: 8317868

Group type: EXPERIMENTAL
Intervention: Reperfusion solution
Number of subjects: 14
Study: 3011061

Group type: EXPERIMENTAL
Intervention: Continuous No. 00‐plain catgut in the vagina; No. 00‐plain catgut interrupted stitches in the perineal muscles and fascia, and No. 00‐nylon interrupted stitches in the skin.
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: No. 0‐polyglycolic acid (Dexon) in all layers.
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Subcuticular technique using No. 0‐polyglycolic acid (Dexon).
Number of subjects: 900

Group type: COMPARATOR
Intervention: Control group (not specified).
Number of subjects: 900
Study: 31183945

Group type: EXPERIMENTAL
Intervention: Eplerenone (200 mg/day for eGFR ≥60 mL/min/1.73 m² or 100 mg/day for eGFR 41-59 mL/min/1.73 m²)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 140
Study: 29054128

Group type: EXPERIMENTAL
Intervention: Combination varenicline/bupropion treatment
Number of subjects: 122

Group type: COMPARATOR
Intervention: Varenicline alone
Number of subjects: 122
Study: 26053270

Group type: EXPERIMENTAL
Intervention: Taliglucerase alfa 30 Units/kg
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Taliglucerase alfa 60 Units/kg
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Taliglucerase alfa (multiple doses)
Number of subjects: 65
Study: 23782896

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB) with standardized medical treatment if needed
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standardized medical treatment (control group)
Number of subjects: 400
Study: 21694591

Group type: EXPERIMENTAL
Intervention: Female dancers
Number of subjects: 36

Group type: COMPARATOR
Intervention: Male dancers
Number of subjects: 36

Group type: COMPARATOR
Intervention: Flat and inclined floors
Number of subjects: 36
Study: 19157343

Group type: EXPERIMENTAL
Intervention: Ultrasound guided technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nerve stimulation guided technique
Number of subjects: 40
Study: 16766775

Group type: EXPERIMENTAL
Intervention: High fruit-vegetable intervention
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Combination high FV, low-fat intervention
Number of subjects: 122

Group type: COMPARATOR
Intervention: Low-fat intervention
Number of subjects: 122